Braidwell »

Bridgebio Pharma shares owned by Braidwell

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Braidwell

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 345k 30.92

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note11/0 (Principal)
Apogee Therapeutics (APGE)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Argenx Se Sponsored Adr (ARGX)
Vaxcyte (PCVX)
Neogenomics Note 0.250% 1/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Insmed Note 1.750% 1/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Penumbra (PEN)

View all positions for Braidwell

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
Laurion Capital Management
UBS Group
Frazier Life Sciences Management
Henderson Group
Cormorant Asset Management
Pictet Asset Management Holding SA
Geode Capital Management
Lord, Abbett & Co
Alliancebernstein
FMR

View all funds holding Bridgebio Pharma